Scimplify raised $25M in an all-equity strategic round in October 2026 led by Hitachi Ventures, with industrial customers Henkel and Teknor Apex joining as investors. Existing backers Accel India, Bertelsmann India Investments, Omnivore, and 3one4 Capital also participated. The round valued Scimplify at a reported $250M post-money, up from $150M in March 2025; the company confirmed $80M in total equity funding but declined to disclose its valuation. The reported valuation was about 1.25x its October annualized revenue run rate.

The company raised a $40M Series B in March 2025 co-led by Accel and Bertelsmann India Investments, with participation from Universal Materials Incubator and existing investors. It previously raised a $9.5M Series A in August 2024 led by Omnivore, alongside Bertelsmann India Investments, 3one4 Capital, and Beenext, following a roughly $3.7M seed round from 3one4 Capital and Beenext in 2023.

Scimplify was founded in 2023 by Salil Srivastava, Sachin Santhosh, and Dheeraj Dhingra. Srivastava previously led the chemicals vertical at Zetwerk, while Santhosh worked at OfBusiness and Bizongo. Their initial thesis was to connect customers needing specialized chemistry with underused factory capacity, while supplying the research and process engineering needed to make that capacity usable.

Scimplify develops and supplies specialty chemicals and advanced materials for manufacturers that need a specific chemical composition, purity, or performance at commercial volumes. A customer can bring a material requirement or a laboratory-proven formulation and use Scimplify to turn it into a repeatable production process, rather than finding a research partner, qualifying a factory, and coordinating production separately.

A typical engagement begins with the customer specifying the material and its requirements. Scientists at Scimplify's Bengaluru and Hyderabad research facilities identify a production route and develop the process; its engineers then match that process to a suitable partner plant and manage technology transfer and scale-up. The factory produces the material, while Scimplify oversees quality, documentation, regulatory requirements, and delivery. Co-founder Sachin Santhosh said some projects had gone from requirements to delivered material in two months, compared with a typical 12–18 months, although timelines vary by project.

Scinode is the software coordinating this workflow. Specialized AI agents support research, manufacturing, and quality control by identifying possible production routes, matching factory capabilities, and retaining customer requirements across projects. Human scientists and engineers oversee execution, including transferring the process into production; the network of more than 500 manufacturing facilities is a partner network rather than a collection of Scimplify-owned factories.

The same operating model serves pharmaceutical ingredients, agrochemicals, personal care and industrial chemicals, and newer advanced materials. Current work includes tungsten derivatives produced from scrap and rare-earth materials, where customers are seeking alternative sources to supply chains concentrated in China.

Scimplify sells chemical development and supply to industrial customers through a managed manufacturing model. Customers pay for the work needed to obtain a specified material and its commercial production; Scimplify coordinates the scientific work and pays manufacturing partners to fulfill orders. Its reported revenue reflects a chemical supply business with production costs, rather than a subscription fee for access to Scinode or a disclosed marketplace commission.

The economic opportunity is to earn a margin for solving process development, factory selection, quality assurance, and delivery together. Partner plants contribute equipment and chemistry-specific production capacity, allowing Scimplify to serve more materials without building a dedicated factory for each one. That reduces the need to own all production assets, but payments to manufacturers, scientific labor, testing, and logistics still have to be covered before sales become profit.

Scimplify recruits factories by offering access to international demand and projects that fill unused capacity. On the customer side, its scientists and local commercial teams provide an entry point for buyers seeking a new material or a second source of supply. Completing qualification creates a route to repeat production orders, although winning an initial development project does not guarantee those orders will reach commercial scale. Customer-investors such as Henkel and Teknor Apex can also help establish industrial credibility as Scimplify enters more demanding applications.

Scimplify competes directly with specialty chemical development and supply platforms including Atomgrid, Mstack, and Distil, which also combine research with external manufacturing capacity. The central contest is who can turn a customer's specification into qualified, consistently delivered material at an acceptable cost; an AI tool or a large factory directory alone does not complete that task.

Atomgrid offers contract development, scaled manufacturing, and sourcing across pharmaceuticals, agrochemicals, personal care, and flavors and fragrances. Mstack combines AI-supported chemical research with manufacturing partners, while Distil connects in-house R&D and qualified production partners in areas including personal care and advanced polymers. These approaches overlap with Scimplify's model, making its breadth of executed projects, factory process knowledge, and ability to retain customers through scale-up more consequential than simply having an AI interface.

Customers can also contract directly with an established chemical manufacturer or keep development and procurement in-house. A factory already qualified for a particular chemistry can offer direct process control and an existing production record, while Scimplify's relative advantage is matching work across many facilities and taking on coordination that the buyer would otherwise manage. Its broader network is most useful when the customer needs a chemistry or production route that an existing supplier cannot readily provide.

Scimplify's initial base in pharmaceutical, agrochemical, and industrial chemicals gives it a route into materials used in semiconductors, batteries, and critical minerals. Expansion requires qualification for new applications and production geographies, extending the business beyond supplying more volume of the same chemicals to existing buyers.

Scimplify is working on rare-earth materials and tungsten derivatives from scrap, alongside materials for electronics and energy. These projects can bring it into procurement budgets aimed at reducing dependence on concentrated Chinese supply, with Hitachi Ventures and industrial customer-investors providing relationships in relevant end markets. Capturing that spending depends on producing at the required purity and consistency, and turning development or pilot batches into approved commercial supply.

About 90% of production was located in India in October 2026, while Scimplify planned to expand its manufacturing network in the U.S. and Japan over the following year. Local production would let it pursue customers needing regional supply and closer technical support, beyond the export business it already serves from India. The company earmarked roughly $7.5M of its latest funding for U.S. expansion, including its manufacturing network, with the allocation subject to change.

Quality at scale. Scimplify coordinates production across more than 500 partner facilities while targeting materials with demanding purity and compliance requirements. A failed batch, inconsistent process transfer, or delayed qualification could interrupt a customer's production and weaken the trust needed to win repeat commercial orders.

Manufacturing economics. The $200M annualized revenue run rate includes a business that must pay for chemical production and fulfillment, while reported EBITDA profitability covered only two months. Expanding into new materials and countries can increase development and operating costs before projects produce repeat orders, so rapid sales growth may not translate into sustained cash generation.

Supply concentration. Roughly 90% of Scimplify's manufacturing remained in India even as overseas customers generated more than half of revenue. Disruptions, tariffs, or customer requirements for local production could constrain its export model before the planned U.S. and Japanese networks are qualified to fulfill orders.